Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2024
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024.06-08-2024